Free Trial

Akoya Biosciences (AKYA) SEC Filings & 10K Form

Akoya Biosciences logo
$2.06 -0.01 (-0.24%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$2.05 -0.01 (-0.44%)
As of 02/21/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Akoya Biosciences SEC Filings

DateFilerForm TypeView
02/11/2025
3:37 PM
Akoya Biosciences (Subject)
Quanterix Corp (Filed by)
Form 425
01/16/2025
8:29 PM
Akoya Biosciences (Filed by)
Quanterix Corp (Subject)
Form SCHEDULE 13D
01/16/2025
5:00 PM
Akoya Biosciences (Subject)
Quanterix Corp (Filed by)
Form SCHEDULE 13D
01/16/2025
8:25 AM
Akoya Biosciences (Subject)
Form 425
01/15/2025
8:04 PM
Akoya Biosciences (Subject)
Quanterix Corp (Filed by)
Form 425
01/14/2025
6:03 AM
Akoya Biosciences (Subject)
Quanterix Corp (Filed by)
Form 425
01/10/2025
3:46 PM
Akoya Biosciences (Subject)
Quanterix Corp (Filed by)
Form 425
01/10/2025
3:24 PM
Akoya Biosciences (Subject)
Form 425
01/10/2025
7:31 AM
Akoya Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:32 AM
Akoya Biosciences (Subject)
Form 425
01/10/2025
7:02 AM
Akoya Biosciences (Subject)
Quanterix Corp (Filed by)
Form 425
12/13/2024
4:18 PM
Akoya Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
4:18 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:19 PM
Akoya Biosciences (Issuer)
Ramachandran Niro Ph.D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:20 PM
Akoya Biosciences (Issuer)
BAMFORD PASCAL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:21 PM
Akoya Biosciences (Issuer)
Ek John Frederick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:22 PM
Akoya Biosciences (Issuer)
Kamocsay Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
6:39 AM
Akoya Biosciences (Subject)
Schindel Yair Chaim (Filed by)
Form SC 13G/A
10/04/2024
5:44 PM
Akoya Biosciences (Issuer)
Mendel Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
8:40 PM
Akoya Biosciences (Issuer)
BAMFORD PASCAL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
8:41 PM
Akoya Biosciences (Issuer)
BAMFORD PASCAL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
9:45 AM
Akoya Biosciences (Subject)
Blue Water Life Science Advisors, LP (Filed by)
Form SC 13G
06/11/2024
3:36 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
8:56 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:53 PM
Akoya Biosciences (Issuer)
Mendel Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:54 PM
Akoya Biosciences (Issuer)
LAI GOLDMAN MYLA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:55 PM
Akoya Biosciences (Issuer)
SCHNETTLER THOMAS P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:56 PM
Akoya Biosciences (Issuer)
Winkler Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:57 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:58 PM
Akoya Biosciences (Issuer)
Raffin Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
5:03 AM
Akoya Biosciences (Filer)
Form DEF 14A
04/23/2024
5:04 AM
Akoya Biosciences (Filer)
Form DEFA14A
04/23/2024
5:05 AM
Akoya Biosciences (Filer)
Form ARS
03/25/2024
4:14 PM
Akoya Biosciences (Issuer)
Ramachandran Niro Ph.D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:16 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:12 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:51 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4/A
03/22/2024
4:54 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:56 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
7:40 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
7:41 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

03/13/2024
3:15 PM
Akoya Biosciences (Subject)
McKelligon Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
5:01 AM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4/A
03/01/2024
8:58 PM
Akoya Biosciences (Issuer)
Ek John Frederick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:52 PM
Akoya Biosciences (Issuer)
Ramachandran Niro Ph.D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:52 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:53 PM
Akoya Biosciences (Issuer)
Kamocsay Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
8:21 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AKYA) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners